Oraya Therapeutics

Oraya Therapeutics was founded in 2007 with an initial investment from Essex Woodlands Health Ventures.


Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on TecDax of the German stock exchange, is one of the world’s leading medical technology companies. The company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumables. The company creates innovative visualization solutions in the field of microsurgery. Carl Zeiss Meditec’s medical technology portfolio is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy. In fiscal year 2013/14 (ended 30 September) the company’s around 3,000 employees generated revenue of EUR 909 million.

Carl Zeiss Meditec headquarters are located in Jena, Germany. The company has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research in India (CARIn) in Bangalore, India, and the Carl Zeiss Innovation Center for Research and Development in Shanghai, China, strengthen the company’s presence in these fast-growing countries. Around 35 percent of Carl Zeiss Meditec shares are in free float. The remaining approx. 65% are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries. Carl Zeiss offers innovative solutions for the future-oriented markets of Medical and Research Solutions, Industrial Solutions, Eye Care and Lifestyle Products. Carl Zeiss AG, Oberkochen, is fully owned by the Carl Zeiss Foundation.

Domain invests primarily in young life science focused businesses with outstanding growth potential. Over its 20-year history, Domain has been involved in the creation of more than 200 companies. Its latest venture capital fund is Domain Partners VIII, which is capitalized at $500 million. Domain is located in Princeton, New Jersey and in Laguna Niguel, California.

Established in 1985, Essex Woodlands is one of the most respected and successful healthcare venture capital and growth equity firms in the world. Essex currently has $2.5 billion under management and is investing out of its eighth fund of $900 million, which closed in 2009.


Scale Venture Partners is a venture firm that invests in information technology companies across the United States. Based in Foster City, California, the ScaleVP team is a long-standing partnership with a consistent, top quartile track record of returns. Scale Venture Partners’ insight-driven investment strategy, extensive operating networks, and go-to-market expertise help identify and build leading portfolio companies in technology and healthcare markets. The ScaleVP team’s proven skill-set and active approach provides entrepreneurs a competitive advantage for growth and category leadership.

Back To Top

© 2015 All rights reserved. Oraya Therapeutics, Inc. The IRay® is a CE-marked medical device. The IRay is not available for sale in the United States. For additional details, including safety and risk information, please see the ORAYA THERAPY section of this website. Oraya, Oraya Therapy, IRay and I-Guide are either trademarks or registered trademarks of Oraya Therapeutics, Inc. in the United States and other countries.